Shots: In the agreement, Aurobindo has obtained the exclusive rights to develop, manufacture & sell COVAXX’s UB-612 vaccine in India & UNICEF & also non-exclusive rights in other selected emerging […]readmore
Tags : Pharma
Shots: Jenburkt became the second company to launch Favivent (favipiravir) to treat mild to moderate COVID-19 symptoms at a price of Rs. 39/tablet Cipla receives the DCGI approval for Ciplenza […]readmore
Shots: Team PharmaShots started their journey on 25 July 2018 and is proudly announcing their completion of one year, with many more to come. PharmaShots has published 1,238 news and […]readmore
1.Janssen’s Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC) Published: 14 Feb,2018 | Tags: Janssen, Erleada, apalutamide, Receives, FDA, Approval, Non-Metastatic Castration-Resistant Prostate Cancer, NM-CRPC 2. Helsinn’s […]readmore
THE US FDA APPROVALS 1. Pfizer’s Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for Anemia Published: 15 May, 2018 | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, […]readmore
PharmaShots Year in Review | Top 10 Pharma News of 2018 1. Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology Portfolio Published: 22 Jan, 2018 | Tags: Celgene, […]readmore
Shots: In Oct, 2018 Pfizer appointed Dr. Albert Bourla as its new CEO, successor of Lan C. Read (7 Dec, 2010 – 31 Dec, 2018) In Feb, 2018 Novartis appointed […]readmore